| Breakdown | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|
Income Statement | ||||
| Total Revenue | 47.48K | 99.99K | 93.57K | 19.00 |
| Gross Profit | 47.48K | 99.99K | 93.57K | 19.00 |
| EBITDA | -504.17K | -549.27K | -474.66K | -380.64K |
| Net Income | -2.22M | -550.47K | -474.95K | -380.63K |
Balance Sheet | ||||
| Total Assets | 2.64M | 4.69M | 5.19M | 6.10M |
| Cash, Cash Equivalents and Short-Term Investments | 585.96K | 1.82M | 2.78M | 4.63M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 85.47K | 130.02K | 118.58K | 606.17K |
| Stockholders Equity | 2.55M | 4.56M | 5.07M | 5.49M |
Cash Flow | ||||
| Free Cash Flow | -1.23M | -960.31K | -1.59M | -473.86K |
| Operating Cash Flow | -448.37K | -460.47K | -568.53K | -448.45K |
| Investing Cash Flow | -783.27K | -499.84K | -1.02M | -25.41K |
| Financing Cash Flow | 0.00 | 0.00 | -265.38K | 4.92M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
48 Neutral | AU$6.14M | -2.11 | -139.36% | ― | 168.85% | 13.51% | |
45 Neutral | AU$4.91M | -7.90 | -127.91% | ― | ― | 80.88% | |
44 Neutral | ― | -1.30 | ― | ― | ― | ― | |
43 Neutral | AU$3.22M | -0.22 | -164.84% | ― | ― | 76.76% | |
42 Neutral | AU$14.95M | -0.72 | 607.07% | ― | ― | 62.50% | |
41 Neutral | AU$4.34M | -2.90 | -42.72% | ― | ― | ― |
Regener8 Resources NL has lodged a notice of a proposed securities issue with the ASX, outlining plans to issue up to 8,000,000 ordinary fully paid shares under a placement or similar capital-raising structure. The new shares, to be issued on 6 May 2026, will expand the company’s equity base and provide additional funding capacity, with implications for existing shareholder dilution and the company’s ability to finance its ongoing projects and strategic objectives.
The announcement formalizes the company’s application for quotation of the new securities on the ASX in line with listing rules, signaling continued reliance on equity markets to support operations. While specific use of proceeds is not detailed, the placement underscores Regener8 Resources’ focus on maintaining access to capital for growth and operational needs in a competitive resources market.
The most recent analyst rating on (AU:R8R) stock is a Hold with a A$0.11 price target. To see the full list of analyst forecasts on Regener8 Resources NL stock, see the AU:R8R Stock Forecast page.
Regener8 Resources NL has notified the ASX of a proposed issue of up to 8 million new ordinary fully paid shares. The securities are to be issued as part of a placement or other type of capital raising, with the proposed issue date set for 12 March 2026.
The move signals the company’s intention to raise additional equity capital, which may be used to support its ongoing operations or growth initiatives. The additional shares will expand the company’s capital base and may have implications for existing shareholders through potential dilution, while potentially strengthening its financial position.
The most recent analyst rating on (AU:R8R) stock is a Hold with a A$0.11 price target. To see the full list of analyst forecasts on Regener8 Resources NL stock, see the AU:R8R Stock Forecast page.
Regener8 Resources has secured firm commitments to raise A$800,000 through a placement of 8 million new shares at A$0.10 each to professional and sophisticated investors, strengthening its funding position for due diligence and exploration at the Srebrenica North project and other existing assets. CPS Capital Group acted as lead manager and will receive a 6% fee, with allotment of the new shares expected around 12 March 2026.
In tandem with the placement, the company plans a non-renounceable pro-rata entitlement offer to raise up to about A$2.03 million, offering one new share for every two held by eligible Australian and New Zealand shareholders at the same A$0.10 issue price. The additional capital is intended to advance the acquisition and initial exploration planning at Srebrenica North, a pair of licences in Bosnia’s historic Srebrenica mining district that host prospective volcanic and intrusive rocks associated with major polymetallic deposits, potentially reshaping Regener8’s growth profile if exploration proves successful.
The most recent analyst rating on (AU:R8R) stock is a Hold with a A$0.11 price target. To see the full list of analyst forecasts on Regener8 Resources NL stock, see the AU:R8R Stock Forecast page.
Regener8 Resources has signed a binding agreement to acquire 100% of the Srebrenica North silver-lead-zinc-copper-antimony project in Bosnia and Herzegovina, giving it a foothold in the prolific Tethyan Metallogenic Belt. The project lies between Mineco’s operating Sase and Veliki Majdan mines and near Middle Island Resources’ Bobija project, in a district with numerous medieval workings but no modern exploration for more than 50 years.
The move positions Regener8 within an emerging European polymetallic hub that has attracted significant foreign investment, highlighted by Dundee Precious Metals’ acquisition of the Vareš Silver Operation and Mineco’s long-term production activities. Regener8 will remain in a trading halt while it completes a capital raising, indicating the company is seeking funding to deploy modern exploration methods and potentially unlock value in this high-grade, mining-friendly jurisdiction.
The most recent analyst rating on (AU:R8R) stock is a Hold with a A$0.11 price target. To see the full list of analyst forecasts on Regener8 Resources NL stock, see the AU:R8R Stock Forecast page.
Regener8 Resources NL has requested a trading halt in its securities on the ASX as it prepares to announce a material acquisition and associated capital raising. Trading in the company’s shares will be suspended until either the announcement is released to the market or the commencement of normal trading on 5 March 2026, signalling a potentially significant change to its asset base and funding structure.
The board-authorised halt underscores that Regener8 considers the pending transaction to be market-sensitive, with possible implications for its growth trajectory and valuation. Stakeholders, including existing shareholders and potential investors, are likely to focus on how the acquisition and capital raising reshape the company’s balance sheet, development pipeline, and competitive positioning in the resources sector.
The most recent analyst rating on (AU:R8R) stock is a Hold with a A$0.11 price target. To see the full list of analyst forecasts on Regener8 Resources NL stock, see the AU:R8R Stock Forecast page.
Regener8 Resources NL has released its interim financial report for the half year ended 31 December 2025, detailing the company’s financial performance, cash flows and changes in equity over the period. The document also includes the directors’ report, auditor’s independence declaration and an independent auditor’s review, underscoring the company’s adherence to ASX reporting and governance requirements and providing investors with updated insight into its financial position.
The report is supported by the company’s established corporate framework, including an external auditor, legal advisers and a professional share registry, reflecting a standard compliance-focused setup for an ASX-listed issuer. While specific operational or strategic updates are not disclosed in the provided extract, the interim accounts and accompanying governance disclosures are a key touchpoint for shareholders tracking Regener8’s financial health and regulatory compliance between full-year results.
The most recent analyst rating on (AU:R8R) stock is a Hold with a A$0.11 price target. To see the full list of analyst forecasts on Regener8 Resources NL stock, see the AU:R8R Stock Forecast page.
Regener8 Resources reported that it has completed a Phase 1 Ultrafine (UFF) soil sampling program at its North Achilles project in the southern Cobar Basin, New South Wales, following the recent execution of a land access agreement. The initial 207-sample campaign, conducted over the south-eastern portion of EL9718 on 100m x 200m spacing, represents the first significant exploration on the tenement and has defined distinct multi-element anomalies (Cu–Au–Ag–Pb) along the Achilles Shear Zone and associated Uabba and Kilparney faults, with anomalous zones extending up to 1.5km. These geochemical footprints are consistent with known polymetallic systems in the Cobar district, including analogues to the Peak and former Hera mines, and are located adjacent to Australian Gold and Copper’s Achilles discovery and maiden 38.5Moz AgEq resource. Against a backdrop of record gold and silver prices, strengthening copper sentiment and strong results from neighbouring explorers, the anomalies at North Achilles enhance Regener8’s exploration pipeline and underscore the project’s potential to deliver a new polymetallic discovery in a proven mineralised corridor.
The most recent analyst rating on (AU:R8R) stock is a Hold with a A$0.12 price target. To see the full list of analyst forecasts on Regener8 Resources NL stock, see the AU:R8R Stock Forecast page.
Regener8 Resources NL has announced promising results from its initial soil sampling at the North Achilles project in New South Wales, utilizing the Ultrafine™ (UFF) method. The results have revealed significant metal anomalies along key geological structures, providing a strong basis for further exploration. This initial exploration marks the first significant investigation of the area, highlighting its potential due to its proximity to Australian Gold and Copper Ltd’s recent discoveries. The findings suggest enhanced prospectivity for the North Achilles project, with plans for additional sampling to refine drill targets.